Alvine Pharmaceuticals' Series A - II Round

Alvine Pharmaceuticals raised a round of funding on September 09, 2009.

Alvine Pharmaceuticals is a clinical-stage, specialty biopharmaceutical company focused on the development of biologics targeting autoimmune and inflammatory diseases, including celiac disease. Alvine…

Articles about Alvine Pharmaceuticals' Series A - II Round: